The nation of Zimbabwe has turned down a major American health deal worth $367m (£272m) spanning five years because of Washington's demand for confidential information.
The decision came to light after a internal memorandum dated December was disclosed, revealing that President Emmerson Mnangagwa believed the deal was "lopsided".
A government spokesman has since clarified that the United States was demanding access to health data for scientific study and commercial gain while was unwilling to guarantee the benefits from future treatments.
"We must now begin the challenging and unfortunate process of winding down our support in Zimbabwe," remarked American envoy to Zimbabwe Pamela Tremont publicly.
The US Embassy noted the US had provided over $1.9bn as health assistance to Zimbabwe during the past two decades.
A physicians' group in Zimbabwe has urged continued talks to secure a deal agreeable to both sides so the country's critical HIV programme can continue.
Wider Background
This development follows a comparable situation in Kenya, where a court suspended a similar deal with the US after legal challenges were filed about the security of citizens' medical information.
Since resuming the presidency recently, US President Donald Trump has drastically cut foreign aid and shut down the key foreign aid agency.
USAID had administered aid for the American government, but Trump argued its expenditure was "wasteful" and his administration was seeking government-to-government agreements to boost openness and responsibility.
As per statements, Sixteen African countries have so far signed these new agreements, constituting over $18.3bn in new funding.
Details of the Rejected Deal
This assistance for Zimbabwe would have supported "combating HIV/Aids, TB, malaria, healthcare for mothers and children, and disease outbreak preparedness.
"We believe this partnership would have delivered immense benefits for the people of Zimbabwe, especially the 1.2 million currently on antiretroviral therapy through US-supported initiatives," Tremont commented.
However, government spokesperson Nick Mangwana said the arrangement was "unequal".
"The proposal required Zimbabwe to share its genetic material and health information indefinitely, without any equivalent guarantee of access to any scientific breakthroughs – such as vaccines, diagnostics, or treatments – that might be developed from that provided information," Mangwana explained.
"Effectively, our nation would supply the raw materials for medical research without any certainty that the end products would be available to our citizens should a future health crisis arise."
Sovereignty and Global Health
He also pointed out that the American exit from the World Health Organization (WHO) and its push of bilateral health agreements were undermining systems previously set up via the international organization.
Mangwana gave as an example its Pathogen Access and Benefit Sharing system designed to manage future global health emergencies.
"This framework is designed to ensure that when a country provides its information, the benefits – including vaccines and treatments – are distributed fairly, not commercialised solely by those with the funds to develop them."
Zimbabwe's reservations regarding the US deal "must not be interpreted as hostility towards the US," he added.
"We are open to further discussions with our US partners on how future co-operation might be structured in a way that respects the sovereignty and interests of each country."
Health Experts Reaction
The Zimbabwe College of Public Health Physicians (ZCPHP) stated it understood the official position, but recommended that negotiations should continue given that a large portion of the nation's HIV programmes depended on foreign aid.
"In cases where specific concerns arise, such as those involving information security or implementation frameworks, these can frequently be addressed through technical clarification and mutually agreed protections," the group commented.
The situation highlights the complex challenges between accepting much-needed foreign assistance and safeguarding a country's data in an increasingly interconnected world.